The company had posted a net profit of Rs 2.79 crore during the same period of previous fiscal.
Net sales of the company, rose to Rs 62.90 crore during the first quarter, as against Rs 54.72 crore during the same period of previous fiscal, RPG Life Sciences Ltd said in a filing to the BSE.
The company said it has received a notice of non-compliance from US Food and Drug Administration during the quarter.
"The company has duly responded to the said notice, however, there is no immediate business impact of this event as the company does not have any exports to USA," the Mumbai-based firm said.
Shares of the company today closed at Rs 65.50 apiece on the BSE, up 1.55% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app